{
  "id": 20327599,
  "title": "FDA Rejects Promising Cancer Drug Developed in China",
  "url": "https://urgent.news/2026/11/16/fda-rejects-promising-cancer-drug-developed-in-china",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T19:38:30.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/lungcancer/123904"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA declined to approve a closely watched drug developed in China for an indication in non-small cell lung cancer (NSCLC), drugmaker Summit Therapeutics announced, though the investigational bispecific antibody could soon...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}